Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases
S Chua, G Gnanasegaran, GJR Cook - Seminars in nuclear medicine, 2009 - Elsevier
In this review, we assess the current role of single-photon emission computed tomography
(SPECT) and positron emission tomography (PET) in the imaging of skeletal metastatic …
(SPECT) and positron emission tomography (PET) in the imaging of skeletal metastatic …
Current treatment modalities for spinal metastases secondary to thyroid carcinoma
YS Kushchayeva, SV Kushchayev, JA Wexler… - Thyroid, 2014 - liebertpub.com
Background: The spine is the most common site of bone metastases due to thyroid cancer,
which develop in more than 3% of patients with well-differentiated thyroid cancer. Nearly half …
which develop in more than 3% of patients with well-differentiated thyroid cancer. Nearly half …
Efficacy and Survival Analysis of 131I Therapy for Bone Metastases from Differentiated Thyroid Cancer
ZL Qiu, HJ Song, YH Xu, QY Luo - The Journal of Clinical …, 2011 - academic.oup.com
Objective: Our objective was to investigate the clinical efficacy of 131I therapy for bone
metastases from differentiated thyroid cancer (DTC) and prognostic factors as well as to …
metastases from differentiated thyroid cancer (DTC) and prognostic factors as well as to …
[HTML][HTML] Surgical management of appendicular skeletal metastases in thyroid carcinoma
RL Satcher, P Lin, N Harun, L Feng, BS Moon… - International journal of …, 2012 - hindawi.com
Background. Bone is a frequent site of metastasis from thyroid carcinoma, but prognostic
factors for patients who have surgery for thyroid carcinoma bone metastases are poorly …
factors for patients who have surgery for thyroid carcinoma bone metastases are poorly …
[HTML][HTML] Low expression of ryanodine receptor 2 is associated with poor prognosis in thyroid carcinoma
N Xu, D Zhang, J Chen, G He… - Oncology Letters, 2019 - spandidos-publications.com
Genetic alterations are vital in the progression of thyroid carcinoma. Ryanodine receptor 2
(RyR2) is reported to serve an important role in several types of human carcinoma …
(RyR2) is reported to serve an important role in several types of human carcinoma …
Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive …
ZL Qiu, CT Shen, QY Luo - Thyroid, 2015 - liebertpub.com
Background: Hyperfunctioning distant metastasis (HFDM) from differentiated thyroid cancer
(DTC) is a rare entity. This study aimed to assess the outcomes of DTC patients presenting …
(DTC) is a rare entity. This study aimed to assess the outcomes of DTC patients presenting …
Follicular thyroid carcinoma with distant metastasis: outcome and prognostic factor
K Sugino, K Kameyama, M Nagahama… - Endocrine …, 2014 - jstage.jst.go.jp
1) Department of Surgery, Ito Hospital, Tokyo 150-8308, Japan 2) Division of Diagnostic
Pathology, Keio University Hospital, Tokyo 160-8582, Japan abstract. Follicular thyroid …
Pathology, Keio University Hospital, Tokyo 160-8582, Japan abstract. Follicular thyroid …
Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone …
ZL Qiu, YL Xue, HJ Song, QY Luo - Nuclear medicine …, 2012 - journals.lww.com
Objective The aim of this study was to compare the diagnostic and prognostic values of 99m
Tc-MDP-planar bone scintigraphy (99m Tc-MDP-BS), 131 I single-photon emission …
Tc-MDP-planar bone scintigraphy (99m Tc-MDP-BS), 131 I single-photon emission …
Natural history of small radioiodine-avid bone metastases that have no structural correlate on imaging studies
E Robenshtok, A Farooki, RK Grewal, RM Tuttle - Endocrine, 2014 - Springer
Bone metastases from differentiated thyroid cancer are generally resistant to radioiodine
(RAI) therapy and are associated with poor prognosis. However, in a recent study from our …
(RAI) therapy and are associated with poor prognosis. However, in a recent study from our …
[HTML][HTML] Treatment and prognosis for patients with differentiated thyroid carcinoma bone metastases
S Wang, J Luo, Z Zhong, X Qi, T Liu, R Qin… - Translational Cancer …, 2020 - ncbi.nlm.nih.gov
Background To investigate reasonable treatment modalities and prognostic factors for
patients with differentiated thyroid carcinoma (DTC) bone metastases (BM). Methods The …
patients with differentiated thyroid carcinoma (DTC) bone metastases (BM). Methods The …